Pamala A. Jacobson

University of Minnesota

H指数:34

被引数:3,873

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Microbiome-Mediated Pharmacokinetics and Informed Dosing of Mycophenolate in Kidney Transplantation

微生物组介导的霉酚酸在肾移植中的药代动力学与指导剂量

Clinical Pharmacokinetics

IF4

2026-10-280

OAAI

Evaluating Vaginal Microbiome Effects on Antiretroviral Exposure in the Female Genital Tract Using Pharmacometric and Machine Learning Approaches

利用药代动力学和机器学习方法评估阴道微生物组对女性生殖道中抗逆转录病毒暴露的影响

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2026-10-030

OAAI

A Review of Population Pharmacokinetic Models and Dosing Algorithms Assessing the Influence of CYP3A5 Genotype and Other Clinical Covariates on Tacrolimus Pharmacokinetics

他克莫司药代动力学受CYP3A5基因型及其他临床协变量影响的群体药代动力学模型和给药剂量算法综述

Clinical Pharmacokinetics

IF4

2026-07-200

PRE

Identification of Microbiome Associations with Tacrolimus Pharmacokinetics in Adult Hematopoietic Cell Transplantation Using Population Pharmacokinetic and Machine Learning

利用群体药代动力学和机器学习方法鉴定成人造血细胞移植中与他克莫司药代动力学相关的微生物组关联

Pharmaceutical Research

IF4.3

2026-07-200

OAAI

Pharmacist workforce training in pharmacogenomics with a focus on rural and underserved areas

药师基因组药学工作队伍培训，重点关注农村和医疗资源匮乏地区

Frontiers in Genetics

IF2.8

2026-04-060

OAAI

A Mycophenolate Pharmacokinetic Study with New Insights into Enterohepatic Recirculation in Kidney Transplant Recipients

一项霉酚酸药代动力学研究，为肾移植受者肠道-肝脏循环提供了新的见解

Clinical Pharmacokinetics

IF4

2026-02-060

OAAI

Integrated Omics Approach to Delineate the Mechanisms of Doxorubicin-Induced Cardiotoxicity

Pharmaceuticals

IF4.8

2026-01-290

Microbiome-Informed Dosing: Exploring Gut Microbial Communities Impact on Mycophenolate Enterohepatic Circulation and Therapeutic Target Achievement

微生物组指导剂量：探索肠道微生物群落对霉酚酸肠肝循环及治疗靶点达成的影響

Clinical Pharmacology & Therapeutics

IF5.5

2025-06-140

OAAI

Pharmacogenomic variation and sedation outcomes during early intensive care unit admission: A pragmatic study

CTS-CLINICAL AND TRANSLATIONAL SCIENCE

IF2.8

2024-12-140

OAAI

Extreme phenotype sampling and next generation sequencing to identify genetic variants associated with tacrolimus in African American kidney transplant recipients

Pharmacogenomics Journal

IF2.9

2024-08-230

PRE

Steroid-tacrolimus drug-drug interaction and the effect of CYP3A genotypes

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2024-07-121

Phase II, Open-Label Clinical Trial of Urinary-Derived Human Chorionic Gonadotropin/Epidermal Growth Factor for Life-Threatening Acute Graft-versus-Host Disease

TRANSPLANTATION AND CELLULAR THERAPY

IF4.4

2023-08-017

OAAI

Comparison of Dose Adjustment Strategies for Obesity in High-dose Cyclophosphamide Among Adult Hematopoietic Cell Transplantation Recipients: Pharmacokinetic Analysis

TRANSPLANTATION AND CELLULAR THERAPY

IF4.4

2022-12-011

OAAI

Public Attitudes toward Pharmacogenomic Testing and Establishing a Statewide Pharmacogenomics Database in the State of Minnesota

公众对药物基因组学测试和在明尼苏达州建立全州药物基因组学数据库的态度

JOURNAL OF PERSONALIZED MEDICINE

IF3

2022-09-303

OAAI

Development and Validation of the Minnesota Assessment of Pharmacogenomic Literacy (MAPL)

药物基因组素养明尼苏达州评估 (MAPL) 的开发和验证

JOURNAL OF PERSONALIZED MEDICINE

IF3

2022-08-296

Fecal β-glucuronidase activity differs between hematopoietic cell and kidney transplantation and a possible mechanism for disparate dose requirements

GUT MICROBES

IF11

2022-08-033

OAAI

Perceptions of pharmacogenetic exceptionalism and the implications for clinical management within an electronic health record

CTS-CLINICAL AND TRANSLATIONAL SCIENCE

IF2.8

2022-07-140

OAAI

Reduced Enterohepatic Recirculation of Mycophenolate and Lower Blood Concentrations Are Associated with the Stool Bacterial Microbiome after Hematopoietic Cell Transplantation

TRANSPLANTATION AND CELLULAR THERAPY

IF4.4

2022-07-0116

OAAI

Exploring Potential for a Personalized Medicine Approach to Smoking Cessation With an American Indian Tribe

NICOTINE & TOBACCO RESEARCH

IF3

2022-06-065

OAAI

Donor and recipient polygenic risk scores influence the risk of post-transplant diabetes

NATURE MEDICINE

IF50

2022-04-0727

PRE

Pamala A. Jacobson

个人简介

教育背景

工作经历

荣誉奖项

研究方向